Cargando…
Surfactant therapy in preterm infants with respiratory distress syndrome and in near-term or term newborns with acute RDS
Many different surfactant preparations derived from animal sources, as well as synthetic surfactants, are available for the treatment of preterm infants with respiratory distress syndrome (RDS). Natural, modified surfactants containing surfactant-associated proteins appear to be more effective than...
Autor principal: | Ramanathan, R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104450/ https://www.ncbi.nlm.nih.gov/pubmed/16625226 http://dx.doi.org/10.1038/sj.jp.7211474 |
Ejemplares similares
-
Regulation of PACAP receptors in respiratory distress syndrome (RDS) of preterms and newborns
por: Müller, MJ, et al.
Publicado: (2015) -
RDS-NExT workshop: consensus statements for the use of surfactant in preterm neonates with RDS
por: Bhandari, Vineet, et al.
Publicado: (2023) -
Aerosolized Surfactant for Preterm Infants with Respiratory Distress Syndrome
por: Brasher, Mandy, et al.
Publicado: (2021) -
Nasal high-frequency oscillatory ventilation (nHFOV) versus nasal continuous positive airway pressure (NCPAP) as an initial therapy for respiratory distress syndrome (RDS) in preterm and near-term infants
por: Iranpour, Ramin, et al.
Publicado: (2019) -
Early Surfactant Therapy for Respiratory Distress Syndrome in Very Preterm Infants
por: Cucerea, Manuela, et al.
Publicado: (2023)